Clinical trials: Congestive Heart Failure, completed
Heart Failure
QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the QuartetTM LV Quadripolar Lead
Optimization and evolution of the patient will be evaluated over 6 months after the implant.
- Trial name
- QUARTO-II (NCT01733368)
- Where
- Spain
- Volunteers
- 198 people
- Sponsor
- Abbott Medical Devices
Congestive Heart Failure
Feasibility of Remote JVP Assessment
The JVPHome is a novel medical device that utilizes machine vision in order to facilitate assessment of jugular venous pressure (JVP) height relative to the sternal angle with the ultimate goal of enabling remote JVP monitoring.
- Trial name
- NCT04807985
- Testing
- JVPHome and ultrasound
- Where
- Canada
- Volunteers
- 24 people
- Sponsor
- Eastern Regional Health Authority
Heart Failure, COPD
Potentially Avoidable Hospitalisation in France
Potentially Avoidable Hospitalizations (Pah) Are Studied As An Indirect Measure Of Access To Primary Care And Of The Interface Between Primary And Secondary Care.
- Conditions
- Heart Failure, COPD, Diabetes
- Trial name
- HPE-LR (NCT02898155)
- Testing
- measure of access to primary care and of the Interface Between Primary ans Secondary Care
- Where
- France
- Volunteers
- 12,000 people
- Sponsor
- University Hospital, Montpellier
Congestive Heart Failure
Establishing Correlation Between Non-invasive Pulmonary Blood Pressure Readings and Swan-Ganz Results
Pulmonary hypertension (PH) is prognostic indicator in heart failure patients for poor outcome, however, it is challenging for monitoring.
- Trial name
- NCT04509089
- Testing
- Suremedix Device
- Where
- Israel
- Volunteers
- 15 people
- Sponsor
- Suremedix Ltd
Heart Failure, Congestive
PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure
The purpose of this study is to determine the value of diagnostic data obtained from Medtronic implantable cardioverter defibrillators (ICDs) with cardiac resynchronization therapy (CRT) to evaluate cardiovascular and heart…
- Trial name
- NCT00279955
- Testing
- Cardiac Resynchronization Therapy Device
- Where
- 93 sites in United States
- Volunteers
- 1,024 people
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure
Heart Failure
Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure
A study to compare the efficacy and safety of eplerenone in Japanese chronic heart failure patients with placebo.
- Trial name
- J-EMPHASIS-HF (NCT01115855)
- Testing
- Eplerenone
- Where
- 54 sites in Japan
- Volunteers
- 221 people
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Congestive Heart Failure
Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event
The study was designed to study the utility of meta-iodobenzylguanidine (123I-mIBG) imaging to identify those participants with heart failure who would experience an adverse cardiac event during 24 months of follow-up from the…
- Trial name
- NCT00785044
- Testing
- I-123 mIBG
- Where
- United States
- Volunteers
- 471 people
- Sponsor
- GE Healthcare
Heart Failure
Intermittent Intravenous Levosimendan in Ambulatory Advanced Chronic Heart Failure Patients
The purpose of this study is to determine the safety and efficacy of intravenous administration of intermittent doses of levosimendan (infusions of 0,2 μg/kg/min, of levosimendan or placebo, without bolus, for 6 hours every 2…
- Trial name
- LION-HEART (NCT01536132)
- Testing
- Levosimendan
- Where
- 13 sites in Spain
- Volunteers
- 70 people
- Sponsor
- Parc de Salut Mar
Heart Failure
Ventilatory Support Associated With Exercise in Heart Failure
Due to the symptoms of heart failure (HF), as dyspnea and fatigue, patients have a reduced functional capacity, evidenced during usual daily activities and exercises.
- Trial name
- SVNI (NCT02384798)
- Testing
- noninvasive ventilatory support, interval training
- Volunteers
- 60 people
- Sponsor
- Federal University of Bahia
Heart Failure, Cardiac Pacing, Artificial
Acute Effects of LBBP Versus BVP for CRT
The study was designed to compare the acute effects of left bundle branch pacing (LBBP) with biventricular pacing (BVP) in patients with left ventricular ejection fraction (LVEF) <=35% with left bundle branch block (LBBB).
- Conditions
- Heart Failure, Cardiac Pacing, Artificial, Cardiac Resynchronization Therapy
- Trial name
- NCT04505384
- Testing
- left bundle branch pacing, biventricular pacing
- Where
- China
- Volunteers
- 25 people
- Sponsor
- Shanghai Zhongshan Hospital
Cardiac Decompensation
Evaluate Heart Failure Patients With Specially Designed Patient Adherence and Monitoring Software on Standard Mobile Devices
This is planned as a feasibility study. The objective is to evaluate a specially designed patient adherence and monitoring software on standard mobile devices in remote monitoring of heart failure patients.
- Trial name
- REMOTE-HF-1 (NCT01430936)
- Where
- 5 sites in United States, India and 1 more
- Volunteers
- 51 people
- Sponsor
- Aventyn, Inc.
Cardiovascular Diseases, Hypertension
Implementing Digital Health in a Learning Health System
The need for new models of integrated care that can improve the efficiency of healthcare and reduce the costs are key priorities for health systems across the United States.
- Conditions
- Cardiovascular Diseases, Hypertension, Heart Failure, Atrial Fibrillation
- Trial name
- ASE-INNOVATE (NCT03713333)
- Testing
- Digital Health Device Diagnostics
- Where
- United States
- Volunteers
- 374 people
- Sponsor
- Scripps Health
Heart Failure Patients
Influence of Sacubitril/Valsartan on Autonomic Cardiac Nervous System in Heart Failure Patients: an Exploratory Study
Sacubitril/valsartan is an angiotensin receptor neprilysin inhibitor with the ability to reduce myocardial hypertrophy, cardiac remodeling and cardiorenal fibrosis.
- Trial name
- NCT04587947
- Testing
- sacubitril/ valsartan
- Where
- Germany
- Volunteers
- 63 people
- Sponsor
- St. Josefs-Hospital Wiesbaden GmbH
Heart Failure
Weight-Based Torsemide Dosing in Subjects With Heart Failure
This study will be a randomized open-label pilot study. The purpose of the study is to compare standard of care outpatient heart failure management versus a weight based torsemide regimen.
- Trial name
- NCT03187509
- Testing
- Torsemide, Standard Outpatient Heart Failure Management
- Where
- United States
- Volunteers
- 52 people, healthy volunteers welcome
- Sponsor
- New York City Health and Hospitals Corporation
Telemedicine, Heart Failure
Electronic Device Implantation Through Remote Guidance
Implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) implants are limited by availability and costs of field clinical specialist (FCS) bioengineers.
- Conditions
- Telemedicine, Heart Failure, Defibrillators
- Trial name
- NCT06404021
- Testing
- interventional cardiology procedures with proctoring system, interventional cardiology procedures with engineer in the electrophysiology laboratory
- Where
- Italy
- Volunteers
- 30 people
- Sponsor
- University of Calabria
Heart Failure
AZD8601 Study in CABG Patients
This is a randomized, double-blind, placebo-controlled, sequential design, multicentre study in patients with moderately impaired systolic function undergoing CABG surgery.
- Trial name
- NCT03370887
- Testing
- AZD8601
- Where
- 10 sites in United States, Finland and 3 more
- Volunteers
- 11 people
- Sponsor
- AstraZeneca
Congestive Heart Failure
Health Literacy in Patients With Congestive Heart Failure
The primary aim of this project is to test the efficacy of an inpatient congestive heart failure (CHF) educational intervention compared with usual care among inpatients at Griffin Hospital, who are largely drawn from the…
- Trial name
- NCT00508716
- Testing
- Health Literacy-Tailored Education
- Where
- United States
- Volunteers
- 124 people
- Sponsor
- Griffin Hospital
Multiple Myeloma
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
1. Planned enrollment period One year (The planned number of patients to be enrolled is set to 400 patients.) Since all patients who are prescribed with Pomalyst are registered in RevMate®, enrollment using the Registration Form…
- Trial name
- NCT02921828
- Where
- 2 sites in United States, Japan
- Volunteers
- 1,149 people
- Sponsor
- Celgene
Left Ventricular Ejection Fraction Less Then or Equal to 50percent
Left Bundle Branch Area Pacing in Heart Failure Patients With Ejection Fraction Below Normal
While cardiac resynchronization therapy remains the mainstay for advanced HF, it is not always feasible due to unfavorable anatomy of coronary sinus or pacing characteristics.
- Trial name
- NCT06148571
- Testing
- left bundle branch area pacing
- Where
- South Korea
- Volunteers
- 142 people
- Sponsor
- Seoul National University Hospital
Heart Diseases
Role of Macrophage Migration Inhibitory Factor (MIF) in Heart Failure
Evaluating the additional value of Macrophage Migration Inhibitory factor (MIF) in cardiovascular diseases when assessed in clinical routine.
- Trial name
- NCT03232671
- Testing
- MIF ELISA
- Where
- Germany
- Volunteers
- 180 people
- Sponsor
- University Hospital, Essen
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.